GlassScriptPhysician profile
Ayman M Latif
NPI 1043488422
$2,796.27
in general payments reported to CMS, 2019-2025
20 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $554 · 2021: $176 · 2022: $204 · 2023: $309 · 2024: $271 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.66 |
| Education | $156.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $702.10 | 2019-2023 | Citrefix, Augment Injectable |
| Davol INC. | $252.27 | 2020-2021 | |
| Celularity INC. | $234.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $216.52 | 2020-2021 | |
| Treace Medical Concepts, INC. | $159.11 | 2022-2025 | |
| Smith+Nephew, INC. | $154.56 | 2025 | Stravix, Grafix, Spatial Frame |
| Mimedx Group, INC. | $143.20 | 2024-2025 | |
| Polaris Technology Solutions LLC | $142.82 | 2025 | |
| Kci USA, INC. | $133.22 | 2019-2022 | |
| Osiris Therapeutics INC. | $121.57 | 2019 | |
| Triad Life Sciences INC. | $118.81 | 2022 | |
| Gotham Surgical Solutions & Devices, INC. | $103.86 | 2019 | |
| Trilliant Surgical LLC. | $83.05 | 2019 | |
| Sebela Pharmaceuticals INC. | $54.17 | 2019-2023 | Naftin |
| Horizon Therapeutics Plc | $44.21 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $39.15 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $28.34 | 2020 | |
| Kairos Surgical INC | $27.76 | 2022 | |
| Alfasigma USA, INC. | $22.75 | 2021 | |
| Organogenesis INC. | $14.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayman Latif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.